Deep brain stimulation (DBS) has evolved considerably over the past 4 decades. Although it
has primarily been used to treat movement disorders such as Parkinson's disease, essential …

Primary prevention trials have shifted their focus to the earliest stages of Alzheimer's disease
(AD). Autopsy data indicates that the neuromodulatory subcortical systems'(NSS) nuclei are …

Neurodegenerative diseases (NDs) are characterized by uncontrolled loss of neuronal cells
leading to a progressive deterioration of brain functions. The transition rate of numerous …

For many neurologists, crossing borders during training is part of the trajectory to becoming
a movement disorders specialist and offers novel insights. In this viewpoint, we discuss how …

Parkinson's disease (PD) is a progressive neurodegenerative disorder caused by the death
of dopaminergic neurons in the substantia nigra and appearance of protein aggregates …

Mild cognitive impairment is present in a number of neurodegenerative disorders including
Parkinson's disease (PD). Mild cognitive impairment in PD (PD-MCI) often manifests as …

Alzheimer's disease (AD) is becoming a prevalent disease in the elderly population. Past
decades have witnessed the development of drug therapies with varying targets. However …

Brain stimulation technology has become a viable modality of reversible interventions in the
effective treatment of many neurological and psychiatric disorders. It is aimed to restore …

As a crucial component of the cerebral cholinergic system and the Papez circuit in the basal
forebrain, dysfunction of the nucleus basalis of Meynert (NBM) is associated with various …

Patients with advanced Alzheimer's disease (AD) experience cognitive impairment and
physical disabilities in daily life. Currently, there are no treatments available to slow down …